Connection
Search Results to
This is a "connection" page, showing the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of
High CA19-9 level in resectable pancreatic cancer is a potential indication of neoadjuvant treatment.
| Property | Value |
|
has major subject area list
|
Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Agents; Chemotherapy, Adjuvant; Deoxycytidine; Gene Expression Regulation, Neoplastic; Pancreatic Neoplasms
|
|
information resource reference
|
Ushida Y, Inoue Y, Ito H, Oba A, Mise Y, Ono Y, Sato T, Saiura A, Takahashi Y. High CA19-9 level in resectable pancreatic cancer is a potential indication of neoadjuvant treatment. Pancreatology. 2021 Jan; 21(1):130-137.
|
|
label
|
High CA19-9 level in resectable pancreatic cancer is a potential indication of neoadjuvant treatment.
|